CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
Open Access
- 24 February 2006
- journal article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 3 (1) , 3
Abstract
We have previously shown that transgenic mice carrying a mutant human APP but deficient in CD40L, display a decrease in astrocytosis and microgliosis associated with a lower amount of deposited Aβ. Furthermore, an anti-CD40L treatment causes a diminution of Aβ pathology in the brain and an improved performance in several cognitive tasks in the double transgenic PSAPP mouse model. Although these data suggest a potential role for CD40L in Alzheimer's disease pathology in transgenic mice they do not cast light on whether this effect is due to inhibition of signaling via CD40 or whether it is due to the mitigation of some other unknown role of CD40L. In the present report we have generated APP and PSAPP mouse models with a disrupted CD40 gene and compared the pathological features (such as amyloid burden, astrocytosis and microgliosis that are typical of Alzheimer's disease-like pathology in these transgenic mouse strains) with appropriate controls. We find that all these features are reduced in mouse models deficient for CD40 compared with their littermates where CD40 is present. These data suggest that CD40 signaling is required to allow the full repertoire of AD-like pathology in these mice and that inhibition of the CD40 signaling pathway is a potential therapeutic strategy in Alzheimer's disease.Keywords
This publication has 18 references indexed in Scilit:
- Genomic regulation after CD40 stimulation in microglia: Relevance to Alzheimer's diseaseMolecular Brain Research, 2005
- Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK PathwayJournal of Biological Chemistry, 2004
- Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer?s diseaseActa Neuropathologica, 2004
- Role of CD40 ligand in amyloidosis in transgenic Alzheimer's miceNature Neuroscience, 2002
- CD40 is expressed and functional on neuronal cellsThe EMBO Journal, 2002
- Identification of CD40 ligand in Alzheimer’s disease and in animal models of Alzheimer’s disease and brain injuryNeurobiology of Aging, 2002
- Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseasesBrain Research, 2000
- Microglial Activation Resulting from CD40-CD40L Interaction After β-Amyloid StimulationScience, 1999
- Activation of microglial cells by β-amyloid protein and interferon-γNature, 1995
- The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formationImmunity, 1994